RNAble

RNAble is a pioneering biotechnology company focused on developing innovative solutions for the treatment of specific cancers and rare genetic diseases. By modulating RNA epitranscriptomics, RNAble aims to alter RNA stability, creating novel therapeutic compounds with the potential to restore the expression of mutated genes and suppress cancer growth.

Located at Ilan Ramon Street 2, 3rd floor, Ness Ziona, 7404905, IL, RNAble leverages cutting-edge research to target components of the RNA epitranscriptomic machinery with small molecules. This approach stabilizes various RNAs, including unstable nonsense mutated transcripts, offering a promising avenue for addressing previously intractable conditions.

RNAble is dedicated to advancing the field of RNA-based therapeutics and improving patient outcomes. We invite the management of RNAble to create a customized and exclusive company showcase and product listing on our platform to further highlight their groundbreaking work.